Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors

類似資料

• Integrative Genomic Characterization and a Genomic Staging System for Gastrointestinal Stromal Tumors
  著者:: Ylipää, Antti, 等
  出版事項: (2010)
• Identification of Preoperative Factors Associated with Outcomes Following Surgical Management of Intra-abdominal Recurrent or Metastatic GIST Following Neoadjuvant Tyrosine Kinase Inhibitor Therapy
  著者:: Roland, Christina L., 等
  出版事項: (2018)
• Accuracy of Preoperative Percutaneous Biopsy for the Diagnosis of Retroperitoneal Liposarcoma Subtypes
  著者:: Ikoma, Naruhiko, 等
  出版事項: (2014)
• Phase I adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma
  著者:: Tseng, William W., 等
  出版事項: (2015)
• Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes
  著者:: Yong, Zachary Zihui, 等
  出版事項: (2021)